99.8%BPC-157
5 mg / vial
A 15-amino-acid pentadecapeptide derived from a gastric protein, widely used in tissue-repair research models.

Purity
99.84%
Current batch
ALP-2601-RETA10
Tested by
Janoshik Analytical
10 mg / vial
A single-molecule triple agonist at the GLP-1, GIP and glucagon receptors, studied in metabolic research models.
Retatrutide is a synthetic peptide engineered to act simultaneously at three incretin and glucagon family receptors. It is the most structurally complex compound in our catalogue and the hardest to synthesise cleanly, which is why we publish the full chromatogram for every batch rather than a purity figure alone.
Peer-reviewed literature on this molecule is limited to laboratory and clinical trial contexts conducted by its originator. Nothing on this page should be read as a claim about human use; the compound is supplied purely as an analytical reference material.
Each batch is assayed for net peptide content, so the stated 10 mg is peptide rather than gross powder weight including counter-ions and residual solvent.
The certificate below belongs to the batch currently shipping. If you already hold a vial, look up its batch number instead.
99.8%5 mg / vial
A 15-amino-acid pentadecapeptide derived from a gastric protein, widely used in tissue-repair research models.
99.89%10 mg / vial
A cyclic lactam analogue of α-MSH used as a reference ligand in melanocortin receptor research.